HomeEducationCOURSE CATALOGCourse Detail

The Future of Body Composition Testing

Program Date: 22 June 2021

Publication Date: 28 October 2021

Continuing Education Units: Nurse Contact: 0.5; Dietitian CPEU: 0.5

Course Description:

In this course, you’ll review current body composition testing techniques for use in research vs. clinical practice; describe current ultrasound technology for measuring muscle mass; and examine new (ultrasound) technologies for testing body composition. Originally presented at the 119th Abbott Nutrition Research Conference as a live webinar on June 22, 2021.

Course Objectives:

• Review current body composition testing techniques for use in research vs. clinical practice.

• Describe current ultrasound technology for measuring muscle mass.

• Examine new (ultrasound) technologies for testing body composition.

CDR Level: 2
Performance Indicators: 8.1.1, 8.1.2
Run Time: 17

Course Instructor Bio(s)

Jeroen Molinger, MSc

Lead Clinical Medical Exercise Physiologist

Duke University Hospital, School of Medicine, Durham, NC, USA

Erasmus Medical Center University Rotterdam

Rotterdam, Netherlands

Dr Jeroen Molinger is Lead Clinical Medical Exercise Physiologist for the Duke Human Physiology and Pharmacology Lab; Program Director and Lead Senior Clinical Medical Exercise Physiologist for the Duke Heart, Cathlab, Cardiology Transplant, and Advanced Heart Failure Group; Program Director and Lead Senior Clinical Medical Exercise Physiologist for the Department of Anesthesiology, Duke Human Pharmacology and Physiology Laboratory; and the Operational and Program Director of the Duke LEEP-COVID Research Taskforce at Duke University Medical Center in Durham, North Carolina. He has a master’s degree in clinical exercise physiology from Maastricht University in the Netherlands and a master’s degree in advanced studies manual therapy from SOMT University in Amersfoort, the Netherlands; he is currently a PhD candidate and research associate at both Duke University Medical Center and Erasmus University Medical Center in Rotterdam, the Netherlands. His PhD focus is on longitudinal energy expenditure and systemic cardiopulmonary, metabolic, and mitochondrial changes of the phenotype during and after COVID-19 infection. In his various positions at Duke University, he focuses on the study of (pre)hospital-based treatments to improve preparation and recovery from major elective surgery, major illness, bone marrow transplant, chemotherapy and critical care across the aging spectrum; autonomic dysfunction in advanced heart failure; and evaluation of longitudinal cardiometabolic pathophysiology in patients with COVID-19 (LEEP-COVID) to understand, guide, and optimize the cardiometabolic care of these high-risk patients.

Carla Prado, PhD, RD

Professor and Campus Alberta Innovate Program (CAIP)

Chair in Nutrition, Food and Health

Director, Human Nutrition Research Unit, Division of Human Nutrition

University of Alberta

Edmonton, Alberta, Canada

Dr Carla Prado is a professor at the University of Alberta in Canada and a Campus Alberta Innovate Program (CAIP) chair in Nutrition, Food and Health. She is also the director of the Human Nutrition Research Unit. Dr Prado received her PhD in human nutrition and metabolism from the University of Alberta, Canada, and is a registered dietitian in both Canada and Brazil. Dr Prado is an expert in assessing nutritional status through the precise measurement of body composition and energy metabolism. The focus of her current research program is to develop targeted nutrition interventions for the prevention and treatment of low muscle mass in patients with diverse conditions. She is currently the principal investigator for four randomized controlled trials investigating the impact of nutrition intervention on body composition and health. She is currently a member of the GLIM Body Composition Working Group, and the Sarcopenic Obesity Consensus Group (ESPEN/EASO). She is an Associate Editor of Clinical Nutrition and the Journal of Cachexia, Sarcopenia and Muscle.

Abbott Nutrition’s Provider Statement for Nursing CEs:

Abbott Nutrition Health Institute is an approved provider of continuing nursing education by the California Board of Registered Nursing Provider #CEP 11213.

Abbott Nutrition’s Provider Statement for Dietitian CPEUs:

Abbott Nutrition Health Institute (RO002), is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR credentialed practitioners will receive continuing professional education units (CPEUs) for completion of this program/materials. Continuing Professional Education Provider Accreditation does not constitute endorsement by CDR of a provider, program, or materials.

In addition to completing an online evaluation, participants of our programs can provide feedback directly to CDR.